Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Vor Biopharma Inc. market cap for the quarter ending 2026-08-06 was $1.4B, a 431.29% increase year-over-year.
Vor Biopharma Inc. market cap for the quarter ending 2026-06-30 was $1B, a 395.59% increase year-over-year.
Vor Biopharma Inc. market cap for the quarter ending 2026-05-07 was $871.31M, a 117.90% increase year-over-year.
Vor Biopharma Inc. market cap for the quarter ending 2026-03-31 was $966.67M, a 46.08% decline year-over-year.
Vor Biopharma Inc. market cap for fiscal 2026 was $1.4B.
Vor Biopharma Inc. market cap for fiscal 2025 was $506.85M, a 265.95% increase from fiscal 2024.
Vor Biopharma Inc. market cap for fiscal 2024 was $138.5M, a 95.47% decline from fiscal 2023.
Vor Biopharma Inc. market cap for fiscal 2023 was $3.06B, a 65.19% decline from fiscal 2022.